We retrospectively reviewed all cases of pneumonia that required hospitalization among allogeneic hematopoietic stem cell transplant (HSCT) recipients with graft-versus-host disease (GVHD) during the period of January 1996 through July 1999. Twelve patients were identified among 88 allogeneic HSCT recipients. All had chronic GVHD and were receiving corticosteroid therapy. Ten of the 12 patients had pulmonary aspergillosis (PA). For 6 of these 10 patients, a gram-negative bacterial pathogen was concurrently isolated from respiratory specimens. At least one-half of the patients with PA had an initial presentation suggestive of bacterial pneumonia; PA was only suspected on the basis of chest CT findings. Aspergillosis is the most common cause of community-acquired pneumonia among allogeneic HSCT recipients with GVHD. CT must be used to exclude an underlying fungal cause in patients who present with a gram-negative pneumonia.
ticosteroid use occurs more frequently among allogeneic transplant recipients [1, 4, 8] . Pulmonary aspergillosis is frequently diagnosed in the outpatient setting in these patients.
In this latter group of HSCT recipients, we noted that gram-negative pathogens were frequently isolated from respiratory specimens at the time of diagnosis of pulmonary aspergillosis. Although invasive aspergillosis has been associated with concurrent cytomegalovirus infection [9] , no significant association has been reported between invasive aspergillosis and bacterial pathogens. Therefore, we undertook a review of the case records of HSCT recipients with GVHD who were hospitalized with a diagnosis of pneumonia and/or pulmonary aspergillosis to determine the significance of this finding.
PATIENTS AND METHODS
Patients and setting. This retrospective study was performed at Wayne State University and Karmanos Cancer Institute (Detroit, Michigan). All patients who received an allogeneic HSCT and who subsequently developed GVHD during the period of January 1996 through July 1999 were identified using the Karmanos Cancer Institute transplant database. Transplant recipients were included in the study if they had been admitted to the hospital with a diagnosis of either pneumonia or pulmonary aspergillosis during the study period. A detailed review of the medical records of these patients was performed. Data analyzed included the following: demographic characteristics; underlying diseases; type of transplant received; medications used, including antimicrobials for prophylaxis; clinical, radiological, and laboratory features of pulmonary infection; and outcome.
Definitions. Pulmonary aspergillosis was defined using the Mycoses Study Group criteria [10] . "Definite pulmonary aspergillosis" was defined as the isolation of Aspergillus species from a lung biopsy specimen that demonstrated positive histopathological evidence (i.e., acutely branching septate hyphae) and a compatible clinical presentation. "Probable pulmonary aspergillosis" was defined as positive histopathological evidence of aspergillosis without isolation of Aspergillus species from the lung biopsy specimen, or as radiographic evidence compatible with pulmonary aspergillosis and identification of Aspergillus species in respiratory secretions, including specimens from sputum, nares, throat, or bronchoalveolar lavage fluid. Radiographic evidence consistent with pulmonary aspergillosis included pulmonary nodule(s) or cavities on a chest radiograph and/or CT scan or as halo or air-crescent signs visible on a CT scan [10] . "Bacterial pneumonia" was defined by the demonstration of a new parenchymal pulmonary infiltrate in a patient with fever and respiratory symptoms if one or both of the following criteria were fulfilled: (1) identification of a bacterial pathogen on culture of a sputum, bronchoalveolar lavage fluid, pleural fluid, or blood specimen, and (2) improvement of pulmonary infiltrates, defervescence for у48 h, and improvement of respiratory symptoms after commencement of empiric antibacterial therapy. GVHD was defined using established criteria [11] .
The study was performed in accordance with the ethical standards of the Institutional Review Board at Wayne State University.
RESULTS
During the 3.5-year study period, we identified 88 recipients of bone marrow transplants and/or peripheral stem cell transplants who had GVHD. Twelve recipients (14%) had been admitted to the hospital from the community with a diagnosis of pneumonia or suspected pulmonary aspergillosis. The clinical characteristics of these patients are summarized in table 1. There were 9 male and 3 female patients, whose ages ranged from 29 to 55 years. Acute myelogenous leukemia (in 5 patients) was the most common reason for transplantation. Most patients ( ) had received a graft from an unrelated donor. n p 10 All patients had chronic GVHD, which involved the skin and bowel in 8 patients, the skin alone in 2 patients, and the bowel alone in 1 patient; the remaining patient had liver disease. One patient (patient 9) also had bronchiolitis obliterans organizing pneumonia (BOOP) of the lungs.
All patients were receiving methylprednisolone as treatment for GVHD at the time of admission as well as either cyclosporin or tacrolimus. In addition, all patients were receiving trimethoprim-sulfamethoxazole (trimethoprim, 160 mg b. The time from transplantation to the onset of pneumonia ranged from 44 to 665 days (median, 181 days). Ten (83%) of the 12 patients presented with cough, and 9 patients (75%) had fever at admission to the hospital. Ten (83%) of the 12 patients (patients 1-10) had pulmonary aspergillosis (definite in 4 patients and probable in 6 patients). Of the remaining 2 patients, one had pneumococcal pneumonia and the other had influenza A-associated pneumonia. A gram-negative bacterial pathogen was concurrently isolated from respiratory specimens obtained from 6 (60%) of the 10 patients with pulmonary aspergillosis (patients 1-6). For 2 of these 6 patients, the gramnegative bacteria were also isolated from blood or pleural fluid specimens, which is consistent with the diagnosis of bacterial pneumonia. In addition, for 5 of the 6 patients, gram-negative bacilli and numerous polymorphonuclear cells were noted on a Gram stain of the respiratory specimen. In all 6 instances, the gram-negative bacterial pathogen was isolated from respiratory secretions obtained concurrently with or before the recovery of Aspergillus species. A single gram-negative pathogen was isolated from 3 of these 6 patients, and multiple gramnegative pathogens were isolated from the other 3 patients. All 6 patients had initial clinical features and chest radiograph findings compatible with bacterial pneumonia, and all received antibiotic therapy directed toward pneumonia due to gramnegative pathogens. None of the patients were neutropenic.
Although all patients had infiltrates noted on their initial chest radiograph, only 5 of the 10 patients who had a final diagnosis of pulmonary aspergillosis had nodular or cavitary infiltrates suggestive of aspergillosis noted on the initial chest radiograph. Eleven of the 12 patients subsequently had CT of the lungs performed р1 week after admission to the hospital. Because of the poor sensitivity of chest radiography for detecting lesions suggestive of pulmonary aspergillosis, CT of the thorax was routinely performed almost immediately after presentation for all HSCT recipients with GVHD who presented with respiratory symptoms and suspected pulmonary aspergillosis. For all 10 patients with pulmonary aspergillosis, either nodular or cavitary lesions compatible with pulmonary aspergillosis were demonstrated on the CT scan.
Aspergillus fumigatus was isolated from lung biopsy specimens in 4 patients, from bronchoalveolar lavage specimens in 3 patients, and from sputum samples in 3 patients. The gramnegative bacterial pathogens isolated from respiratory secretions were Pseudomonas aeruginosa (in 4 patients), Enterobacter cloacae (in 3), Klebsiella pneumoniae (in 1), and Citrobacter freundii (in 1). One patient each also had E. cloacae or K. pneumoniae recovered from blood or pleural fluid specimens, respectively. Seven of the 9 gram-negative bacterial isolates were resistant to trimethoprim-sulfamethoxazole. Patient 11, who had pneumococcal pneumonia, had S. pneumoniae isolated with an MIC of penicillin of 1.0 mg/mL. All 9 patients with an antemortem diagnosis of pulmonary aspergillosis were treated with amphotericin B, and only 1 patient survived.
DISCUSSION
In this study, pulmonary aspergillosis was the most common cause (in 83% of patients) of late-onset community-acquired pneumonia among hospitalized HSCT recipients with chronic GVHD. This is consistent with the increasing incidence of lateonset invasive aspergillosis recently reported among allogeneic HSCT recipients with GVHD [2, 4, 5] . In 6 of the 10 patients with pulmonary aspergillosis, a gram-negative bacterial pathogen was concurrently isolated from respiratory secretions. Furthermore, for 5 of these 6 patients, the initial clinical presentation and chest radiograph findings were compatible with bacterial pneumonia. The concurrent occurrence of pulmonary infection or colonization with gram-negative bacilli and the subsequent identification of pulmonary aspergillosis in HSCT recipients with chronic GVHD, to our knowledge, has not been previously reported. It appears analogous to the frequent colonization of the respiratory tract with Pseudomonas and Aspergillus species in patients with cystis fibrosis, and it may reflect local pathophysiological mechanisms involving the respiratory mucosa.
Although the recovery of bacteria from respiratory secretions may not necessarily imply infection, in 2 of 6 patients, the same pathogen was recovered from blood and pleural fluid specimens. At admission to the hospital, all 6 patients initially had a clinical presentation and a finding of infiltrates on a chest radiograph compatible with bacterial pneumonia. Moreover, in such severely immunosuppressed patients with pneumonia, the recovery of potential pathogens, such as P. aeruginosa and E. cloacae, would likely warrant appropriate antibiotic therapy in addition to antifungal therapy. Clinical improvement after treatment with antibacterials was noted in 2 of 6 patients. Responses in the other patients could not be determined, because those patients died soon after admission to the hospital.
Gram-negative bacillary pneumonia caused by P. aeruginosa or E. cloacae generally occurs in the first 100 days after transplantation [7, 12] . However, in patients with chronic GVHD, Pseudomonas pneumonia can occur late after transplantation and is associated with significant mortality [13] . The high over-all mortality rate in our patients with pulmonary aspergillosis (90%), which occurred despite administration of treatment, is similar to that reported elsewhere and likely reflects the severely immunosuppressed status of the patients with chronic GVHD who were receiving steroids [4, 8] . The contribution of coinfection with gram-negative bacteria to mortality is uncertain, although, in a study of infections that occurred 3 months after transplantation, only 1 of 6 patients with Pseudomonas pneumonia survived [13] .
Among the nonfungal pathogens responsible for late-onset community-acquired pneumonia in HSCT recipients, community-acquired respiratory viruses appear to be common [5] . The incidence of cytomegalovirus pneumonia has been significantly reduced with the use of ganciclovir prophylaxis [13] . Likewise, the use of trimethoprim-sulfamethoxazole prophylaxis has decreased the incidence of pneumonia caused by P. carinii, and prophylaxis with penicillin has similarly resulted in fewer cases of pneumonia caused by S. pneumoniae and Haemophilus influenzae. However, cases of late-onset pneumonia caused by these organisms are still reported in patients who have not received appropriate prophylaxis [5, 12, 13] . The use of these prophylactic agents might explain the paucity of these pathogens noted in our study. Most (7 of 9) of the gram-negative bacteria isolated in our study were resistant to trimethoprim-sulfamethoxazole, and the single isolate of S. pneumoniae recovered was resistant to penicillin. Thus, the prolonged use of antibiotic prophylaxis in our patients might have resulted in colonization and subsequent late-onset infection with these drug-resistant pathogens. Because trimethoprim-sulfamethoxazole and penicillin prophylaxis are routinely used at many hematopoietic stem cell transplantation centers, the incidence of infection caused by pathogens that are resistant to these agents may increase in the future.
Associated pulmonary aspergillosis was suspected on the basis of findings of subsequent CT scans. Chest CT detected pulmonary nodules and/or cavitary lesions suggestive of aspergillosis in all 10 patients, but in only 5 patients on the initial chest radiograph. Thus, without CT scans, 5 (50%) of the 10 cases might have been treated as bacterial pneumonia, and the coexisting pulmonary aspergillosis might have been missed. This finding is in agreement with the reported utility of chest CT for the diagnosis and management of invasive aspergillosis in high-risk patients [14, 15] .
The study has the inherent limitations of a retrospective review, and the number of patients studied was small. We identified only HSCT recipients with GVHD who were admitted to the hospital with either pneumonia or aspergillosis. Therefore, similar patients who had mild symptoms of communityacquired respiratory infection and who were treated as outpatients were excluded.
In conclusion, in HSCT recipients with chronic GVHD, pulmonary aspergillosis is the most common cause of community-acquired pneumonia requiring hospitalization. Frequently, pulmonary aspergillosis was associated with gramnegative bacterial pathogens, such as P. aeruginosa and E. cloacae. Therefore, it is important to exclude the presence of pulmonary aspergillosis using CT in high-risk patients who present with possible community-acquired pneumonia due to gram-negative pathogens.
MEMBERS OF THE BONE MARROW TRANSPLANT GROUP
S. Abella, MD, R. Baynes, MD, R. Dansey, MD, C. Hamm, MD, and J. Klein, MD.
